82 related articles for article (PubMed ID: 16256355)
1. Direct observation (NMR) of the efficacy of glucagon receptor antagonists in murine liver expressing the human glucagon receptor.
Cohen SM; Duffy JL; Miller C; Kirk BA; Candelore MR; Ding VD; Kaczorowski G; Tota LM; Werrmann JG; Wright M; Parmee ER; Tata JR; Zhang BB
Bioorg Med Chem; 2006 Mar; 14(5):1506-17. PubMed ID: 16256355
[TBL] [Abstract][Full Text] [Related]
2. Hepatic glucagon receptor binding and glucose-lowering in vivo by peptidyl and non-peptidyl glucagon receptor antagonists.
Dallas-Yang Q; Shen X; Strowski M; Brady E; Saperstein R; Gibson RE; Szalkowski D; Qureshi SA; Candelore MR; Fenyk-Melody JE; Parmee ER; Zhang BB; Jiang G
Eur J Pharmacol; 2004 Oct; 501(1-3):225-34. PubMed ID: 15464082
[TBL] [Abstract][Full Text] [Related]
3. Discovery of potent, orally active benzimidazole glucagon receptor antagonists.
Kim RM; Chang J; Lins AR; Brady E; Candelore MR; Dallas-Yang Q; Ding V; Dragovic J; Iliff S; Jiang G; Mock S; Qureshi S; Saperstein R; Szalkowski D; Tamvakopoulos C; Tota L; Wright M; Yang X; Tata JR; Chapman K; Zhang BB; Parmee ER
Bioorg Med Chem Lett; 2008 Jul; 18(13):3701-5. PubMed ID: 18539028
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel, potent, and orally active spiro-urea human glucagon receptor antagonists.
Shen DM; Zhang F; Brady EJ; Candelore MR; Dallas-Yang Q; Ding VD; Dragovic J; Feeney WP; Jiang G; McCann PE; Mock S; Qureshi SA; Saperstein R; Shen X; Tamvakopoulos C; Tong X; Tota LM; Wright MJ; Yang X; Zheng S; Chapman KT; Zhang BB; Tata JR; Parmee ER
Bioorg Med Chem Lett; 2005 Oct; 15(20):4564-9. PubMed ID: 16102966
[TBL] [Abstract][Full Text] [Related]
5. Cloning and expression of canine glucagon receptor and its use to evaluate glucagon receptor antagonists in vitro and in vivo.
Yang X; Yates ML; Candelore MR; Feeney W; Hora D; Kim RM; Parmee ER; Berger JP; Zhang BB; Qureshi SA
Eur J Pharmacol; 2007 Jan; 555(1):8-16. PubMed ID: 17140563
[TBL] [Abstract][Full Text] [Related]
6. Discovery and investigation of a novel class of thiophene-derived antagonists of the human glucagon receptor.
Duffy JL; Kirk BA; Konteatis Z; Campbell EL; Liang R; Brady EJ; Candelore MR; Ding VD; Jiang G; Liu F; Qureshi SA; Saperstein R; Szalkowski D; Tong S; Tota LM; Xie D; Yang X; Zafian P; Zheng S; Chapman KT; Zhang BB; Tata JR
Bioorg Med Chem Lett; 2005 Mar; 15(5):1401-5. PubMed ID: 15713396
[TBL] [Abstract][Full Text] [Related]
7. Discovery of N-aryl-2-acylindole human glucagon receptor antagonists.
Sinz C; Bittner A; Brady E; Candelore M; Dallas-Yang Q; Ding V; Jiang G; Lin Z; Qureshi S; Salituro G; Saperstein R; Shang J; Szalkowski D; Tota L; Vincent S; Wright M; Xu S; Yang X; Zhang B; Tata J; Kim R; Parmee ER
Bioorg Med Chem Lett; 2011 Dec; 21(23):7124-30. PubMed ID: 22030028
[TBL] [Abstract][Full Text] [Related]
8. Discovery of cyclic guanidines as potent, orally active, human glucagon receptor antagonists.
Sinz C; Chang J; Lins AR; Brady E; Candelore M; Dallas-Yang Q; Ding V; Jiang G; Lin Z; Mock S; Qureshi S; Salituro G; Saperstein R; Shang J; Szalkowski D; Tota L; Vincent S; Wright M; Xu S; Yang X; Zhang B; Tata J; Kim R; Parmee E
Bioorg Med Chem Lett; 2011 Dec; 21(23):7131-6. PubMed ID: 22001094
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of conformationally constrained tri-substituted ureas as potent antagonists of the human glucagon receptor.
Liang R; Abrardo L; Brady EJ; Candelore MR; Ding V; Saperstein R; Tota LM; Wright M; Mock S; Tamvakopolous C; Tong S; Zheng S; Zhang BB; Tata JR; Parmee ER
Bioorg Med Chem Lett; 2007 Feb; 17(3):587-92. PubMed ID: 17126016
[TBL] [Abstract][Full Text] [Related]
10. A novel glucagon receptor antagonist inhibits glucagon-mediated biological effects.
Qureshi SA; Rios Candelore M; Xie D; Yang X; Tota LM; Ding VD; Li Z; Bansal A; Miller C; Cohen SM; Jiang G; Brady E; Saperstein R; Duffy JL; Tata JR; Chapman KT; Moller DE; Zhang BB
Diabetes; 2004 Dec; 53(12):3267-73. PubMed ID: 15561959
[TBL] [Abstract][Full Text] [Related]
11. Human glucagon receptor antagonists with thiazole cores. A novel series with superior pharmacokinetic properties.
Madsen P; Kodra JT; Behrens C; Nishimura E; Jeppesen CB; Pridal L; Andersen B; Knudsen LB; Valcarce-Aspegren C; Guldbrandt M; Christensen IT; Jørgensen AS; Ynddal L; Brand CL; Bagger MA; Lau J
J Med Chem; 2009 May; 52(9):2989-3000. PubMed ID: 19385613
[TBL] [Abstract][Full Text] [Related]
12. New beta-alanine derivatives are orally available glucagon receptor antagonists.
Lau J; Behrens C; Sidelmann UG; Knudsen LB; Lundt B; Sams C; Ynddal L; Brand CL; Pridal L; Ling A; Kiel D; Plewe M; Shi S; Madsen P
J Med Chem; 2007 Jan; 50(1):113-28. PubMed ID: 17201415
[TBL] [Abstract][Full Text] [Related]
13. Anti-diabetic efficacy and impact on amino acid metabolism of GRA1, a novel small-molecule glucagon receptor antagonist.
Mu J; Qureshi SA; Brady EJ; Muise ES; Candelore MR; Jiang G; Li Z; Wu MS; Yang X; Dallas-Yang Q; Miller C; Xiong Y; Langdon RB; Parmee ER; Zhang BB
PLoS One; 2012; 7(11):e49572. PubMed ID: 23185367
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel, potent, selective, and orally active human glucagon receptor antagonists containing a pyrazole core.
Shen DM; Brady EJ; Candelore MR; Dallas-Yang Q; Ding VD; Feeney WP; Jiang G; McCann ME; Mock S; Qureshi SA; Saperstein R; Shen X; Tong X; Tota LM; Wright MJ; Yang X; Zheng S; Chapman KT; Zhang BB; Tata JR; Parmee ER
Bioorg Med Chem Lett; 2011 Jan; 21(1):76-81. PubMed ID: 21147532
[TBL] [Abstract][Full Text] [Related]
15. Generation of mice expressing the human glucagon receptor with a direct replacement vector.
Shiao LL; Cascieri MA; Trumbauer M; Chen H; Sullivan KA
Transgenic Res; 1999 Aug; 8(4):295-302. PubMed ID: 10621976
[TBL] [Abstract][Full Text] [Related]
16. Quantification of the glycogen 13C-1 NMR signal during glycogen synthesis in perfused rat liver.
Bergans N; Dresselaers T; Vanhamme L; Van Hecke P; Van Huffel S; Vanstapel F
NMR Biomed; 2003 Feb; 16(1):36-46. PubMed ID: 12577296
[TBL] [Abstract][Full Text] [Related]
17. Discovery and structure-activity relationship of the first non-peptide competitive human glucagon receptor antagonists.
Madsen P; Knudsen LB; Wiberg FC; Carr RD
J Med Chem; 1998 Dec; 41(26):5150-7. PubMed ID: 9857085
[TBL] [Abstract][Full Text] [Related]
18. Cloning and characterization of the glucagon receptor from cynomologous monkey.
McNally T; Grihalde ND; Pederson TM; Ogiela CA; Djuric SW; Collins CA; Lin CW; Reilly RM
Peptides; 2004 Jul; 25(7):1171-8. PubMed ID: 15245877
[TBL] [Abstract][Full Text] [Related]
19. Biaryl amide glucagon receptor antagonists.
Kurukulasuriya R; Sorensen BK; Link JT; Patel JR; Jae HS; Winn MX; Rohde JR; Grihalde ND; Lin CW; Ogiela CA; Adler AL; Collins CA
Bioorg Med Chem Lett; 2004 May; 14(9):2047-50. PubMed ID: 15080976
[TBL] [Abstract][Full Text] [Related]
20. A novel series of indazole-/indole-based glucagon receptor antagonists.
Lin S; Zhang F; Jiang G; Qureshi SA; Yang X; Chicchi GG; Tota L; Bansal A; Brady E; Trujillo M; Salituro G; Miller C; Tata JR; Zhang BB; Parmee ER
Bioorg Med Chem Lett; 2015 Oct; 25(19):4143-7. PubMed ID: 26303893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
